Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies.
about
The cholinergic hypothesis of Alzheimer's disease: a review of progressPlasma and CSF Abeta for the longitudinal prediction of Alzheimer's disease dementia and other dementias in people with cognitive decline but no dementiaMDL 26,479: a potential cognition enhancer with benzodiazepine inverse agonist-like propertiesAlzheimer's therapeutics: translation of preclinical science to clinical drug developmentThe pharmacological landscape and therapeutic potential of serine hydrolasesAlzheimer's disease: Targeting the Cholinergic SystemEffect of Estradiol on Neurotrophin Receptors in Basal Forebrain Cholinergic Neurons: Relevance for Alzheimer's DiseaseMemory and attention in patients with senile dementia of the Alzheimer type and in normal elderly subjectsFluorescence spectroscopy approaches for the development of a real-time organophosphate detection system using an enzymatic sensorRapid alteration of protein phosphorylation during postmortem: implication in the study of protein phosphorylationGenetic risk factors in Alzheimer's diseaseCSF monoamine metabolites, cholinesterases and lactate in the adult hydrocephalus syndrome (normal pressure hydrocephalus) related to CSF hydrodynamic parameters.Brain metabolism in Alzheimer's dementia: studies of 11C-deoxyglucose accumulation, CSF monoamine metabolites and neuropsychological test performance in patients and healthy subjectsCholinergic system and constructional praxis: a further study of physostigmine in Alzheimer's diseaseA double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease.Neuropsychological syndromes in presenile dementia due to cerebral atrophy.Changes in the human visual evoked potential caused by the anticholinergic agent hyoscine hydrobromide: comparison with results in Alzheimer's diseaseAlzheimer's disease: a correlative studyThe effect of APOE ε4 allele on cholinesterase inhibitors in patients with Alzheimer disease: evaluation of the feasibility of resting state functional connectivity magnetic resonance imaging.Cortical M1 receptor concentration increases without a concomitant change in function in Alzheimer's disease.A cell line producing recombinant nerve growth factor evokes growth responses in intrinsic and grafted central cholinergic neurons.Experimental neurotrophic factor therapy leads to cortical synaptic remodeling and compensates for behavioral deficits.The molecular mechanisms of scrapie encephalopathy and relevance to human neurodegenerative disease.Multiple dose pharmacokinetics, safety, and tolerance of velnacrine (HP 029) in healthy elderly subjects: a potential therapeutic agent for Alzheimer's disease.The transport of choline.Alzheimer disease therapeutics.Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014Hypoxia alters expression of zebrafish microtubule-associated protein tau (mapta, maptb) gene transcripts.Brain ageing in the new millennium.Protein and nucleic acid content in the aging human brain.Autism brain tissue banking.Alzheimer's disease and metals: a review of the involvement of cellular membrane receptors in metallosignalling.Parkinson's disease and Alzheimer's disease as disorders of the isodendritic core.Biochemistry of DementiasChemical pathology of brain degeneration.IGF2 ameliorates amyloidosis, increases cholinergic marker expression and raises BMP9 and neurotrophin levels in the hippocampus of the APPswePS1dE9 Alzheimer's disease model mice.Early neurone loss in Alzheimer's disease: cortical or subcortical?Surgical treatment of sleep-apnea-associated psychosis.Therapeutic approaches to age-associated neurocognitive disordersBrain aging research at the close of the 20th century: from bench to bedside.
P2860
Q22242019-48326C64-D39B-4F33-85B8-BCB923BFC9DBQ24235058-24A85C54-87C2-47CF-9C66-AD90DFF25DC7Q24680363-9B25EAFA-3A25-4382-AF8B-62EC806EB15DQ26829267-1B4E81E3-6783-4D8B-9B2A-30088B7D33F4Q26995817-04AC3499-9610-4D33-8A20-8EB0095C1F56Q28070135-59212C80-090D-45DC-9142-D07E125A36D9Q28071845-FBC1A0E1-EC58-4935-8F65-CC506C881316Q28333982-70F5C3EB-192A-476C-AFDC-A8CEEAF4FED9Q28390209-7C33F7D5-C8C5-464D-A61A-3CD23D3EFB45Q28392483-58038B97-19B5-4683-AB7B-FE2608257DF9Q33588353-31CD1229-D0F1-4653-9976-14DFABDA7008Q33589450-F1B088A7-DE81-4CA4-AE23-1D1D971BE166Q33589643-E8EAFDB3-E71E-4D6D-9C7C-A9C4516A3816Q33619760-A7188A8C-897A-42B1-88A4-6C5828CF9956Q33621285-73D850A5-0784-4AA7-8F95-C15F5FA1109BQ33621936-291844A6-F89C-468F-9BC2-EE2F9746D3B1Q33621942-E7C24F62-9891-4CEE-98A3-05C8ED75640DQ33621991-C513003E-76A5-4B98-87BC-C98A85DC0449Q33624389-48F70222-1381-4ECA-9F9B-B71CA9DD30BCQ33830572-51ACFC67-DB81-4CDD-8AA9-6F98158C6179Q33864505-85F2BC41-A218-413B-AEE0-AB0B43EA0C0AQ33921847-49CBA22B-F5C1-47A3-8927-77121E2831F4Q34081152-076C7E2D-2A9F-4985-B5BB-2161813FE0B7Q34147354-96F7A236-1419-4CC1-804E-1E78938B24CAQ34149885-54469A99-6AF4-4380-988C-57475A6B726CQ34393812-E415F206-3585-4553-8C1D-E729D56A69E8Q34408888-945A529D-58F7-41D7-A68B-2B86EDB8D2F0Q34537350-70F6E1BA-9D35-4F87-94D9-248076AC2FE2Q34625093-51922A2A-521C-4BE9-9900-CFB4E949837BQ34698235-8DD37180-DCCE-4915-BC98-E51A306E9175Q34699027-F399D500-D1EF-4EAB-B6D0-36B851B31A3FQ34725385-F0B8A9FC-E7A9-4514-835A-8A8953D95724Q34785967-9058971C-F798-448B-86E3-DF5480529C7DQ34982070-B0B9ACDD-B606-4D4F-8EBB-EE41C9CF8939Q34982150-F5F09F55-CFCC-4935-9311-3DBB50853D1BQ35147651-7DA67CA1-0586-45FD-AE4C-F1F0FB517717Q35176873-F87B54E5-0401-4182-B5CD-ACDD1A4C6438Q35229819-C328E3C5-8018-4CA0-9D9F-FD75B5829C24Q35236387-AD9D4ECF-29BA-401D-A3AC-E6904EDC8C9AQ35236407-C9921CD8-F892-47E6-93EB-EECA511E9B0C
P2860
Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies.
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
1976年论文
@zh
1976年论文
@zh-cn
name
Neurotransmitter-related enzym ...... mentia and other abiotrophies.
@en
Neurotransmitter-related enzym ...... mentia and other abiotrophies.
@nl
type
label
Neurotransmitter-related enzym ...... mentia and other abiotrophies.
@en
Neurotransmitter-related enzym ...... mentia and other abiotrophies.
@nl
prefLabel
Neurotransmitter-related enzym ...... mentia and other abiotrophies.
@en
Neurotransmitter-related enzym ...... mentia and other abiotrophies.
@nl
P2093
P921
P356
P1433
P1476
Neurotransmitter-related enzym ...... mentia and other abiotrophies.
@en
P2093
P304
P356
10.1093/BRAIN/99.3.459
P407
P577
1976-09-01T00:00:00Z